PL2538918T3 - Cytocholina do leczenia jaskry - Google Patents

Cytocholina do leczenia jaskry

Info

Publication number: PL2538918T3
Authority: PL; Poland
Prior art keywords: citicoline; glaucoma; treatment
Prior art date: 2010-02-22

Application number

PL11711656T

Other languages

English (en)

Inventor

Cristiano Virno

Marco Malizia

Original Assignee

Omikron Italia S R L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-02-22

Filing date

2011-02-17

Publication date

2015-05-29

2011-02-17 Application filed by Omikron Italia S R L filed Critical Omikron Italia S R L

2015-05-29 Publication of PL2538918T3 publication Critical patent/PL2538918T3/pl

Links

RZZPDXZPRHQOCG-OJAKKHQRSA-M CDP-choline(1-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-M 0.000 title 1
208000010412 Glaucoma Diseases 0.000 title 1
229960001284 citicoline Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL11711656T 2010-02-22 2011-02-17 Cytocholina do leczenia jaskry PL2538918T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ITRM2010A000071A IT1398378B1 (it)	2010-02-22	2010-02-22	Citicolina per il trattamento del glaucoma e dell'ipertensione oculare.
EP11711656.6A EP2538918B1 (en)	2010-02-22	2011-02-17	Citicoline for the treatment of glaucoma
PCT/IB2011/050663 WO2011101802A1 (en)	2010-02-22	2011-02-17	Citicoline for the treatment of glaucoma and ocular hypertension

Publications (1)

Publication Number	Publication Date
PL2538918T3 true PL2538918T3 (pl)	2015-05-29

Family

ID=42790833

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11711656T PL2538918T3 (pl)	2010-02-22	2011-02-17	Cytocholina do leczenia jaskry

Country Status (7)

Country	Link
US (1)	US8822429B2 (pl)
EP (1)	EP2538918B1 (pl)
JP (1)	JP5801324B2 (pl)
ES (1)	ES2528366T3 (pl)
IT (1)	IT1398378B1 (pl)
PL (1)	PL2538918T3 (pl)
WO (1)	WO2011101802A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITRM20120284A1 (it) *	2012-06-18	2013-12-19	Omikron Italia S R L	Citicolina per il trattamento della retinopatia diabetica.
ITMI20121223A1 (it) *	2012-07-13	2014-01-14	Gregorio Fabio De	Nuova composizione farmacologica comprendente citicolina in combinazione con glicerolo e/o acetazolamide
US9163055B2 (en) *	2012-09-28	2015-10-20	Tufts University	Methods for treating glaucoma using uridine diphosphate derivatives
SI2968385T1 (sl)	2013-03-13	2018-10-30	Tufts University	Uridin nukleozid derivati, sestavki in metode uporabe
ITUA20161679A1 (it) *	2016-03-15	2017-09-15	Neuraxpharm Italy S P A	Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi
IT201600103956A1 (it) *	2016-10-17	2018-04-17	Omikron Italia S R L	Formulazione oftalmica comprendente citicolina veicolata da liposomi per il trattamento del glaucoma
WO2022238833A1 (en) *	2021-05-10	2022-11-17	Omikron Italia S.R.L.	Oral solution based on citicoline and nicotinamide for use in the treatment of glaucoma
IT202200021624A1 (it) *	2022-10-20	2024-04-20	Sifi Spa	Composizione nutraceutica ad effetto neuroprotettivo per il trattamento del glaucoma
WO2026009194A1 (en)	2024-07-05	2026-01-08	Fidia Farmaceutici S.P.A.	Pharmaceutical compositions for the prevention and/or treatment of degeneration of the optic nerve and retinal nerve cells resulting from glaucoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9303627D0 (sv) *	1993-11-03	1993-11-03	Kabi Pharmacia Ab	Method and means for prevention of cataract

2010
- 2010-02-22 IT ITRM2010A000071A patent/IT1398378B1/it active
2011
- 2011-02-17 PL PL11711656T patent/PL2538918T3/pl unknown
- 2011-02-17 US US13/580,181 patent/US8822429B2/en active Active
- 2011-02-17 ES ES11711656.6T patent/ES2528366T3/es active Active
- 2011-02-17 EP EP11711656.6A patent/EP2538918B1/en active Active
- 2011-02-17 WO PCT/IB2011/050663 patent/WO2011101802A1/en not_active Ceased
- 2011-02-17 JP JP2012553433A patent/JP5801324B2/ja active Active

Also Published As

Publication number	Publication date
EP2538918A1 (en)	2013-01-02
JP2013520406A (ja)	2013-06-06
WO2011101802A1 (en)	2011-08-25
US20120316128A1 (en)	2012-12-13
ES2528366T3 (es)	2015-02-09
EP2538918B1 (en)	2014-11-19
ITRM20100071A1 (it)	2011-08-23
JP5801324B2 (ja)	2015-10-28
US8822429B2 (en)	2014-09-02
IT1398378B1 (it)	2013-02-22

Similar Documents

Publication	Publication Date	Title
ZA201404121B (en)	2016-07-27	Compositions for the treatment of dry eye
EP2621499A4 (en)	2014-04-09	METHODS OF TREATING ALLERGIC DISEASES
ZA201403795B (en)	2016-01-27	Formulations for the treatment of diabetes
SG10201509919UA (en)	2016-01-28	Treatment of jak2-mediated conditions
SG2014014724A (en)	2014-07-30	METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
PL2538918T3 (pl)	2015-05-29	Cytocholina do leczenia jaskry
ZA201403430B (en)	2016-05-25	4-pregenen- 11ss -17 - 21-triols-3, 20- dione derivatives for the treatment of ocular conditions
IL230960A0 (en)	2014-03-31	A device for the treatment of eye disease
IL225896A0 (en)	2013-06-27	Treatment of mecp-2 related disorders
IL231593B (en)	2019-01-31	Buprenorphine for the treatment of acute suicidality
IL230959A0 (en)	2014-03-31	A device for the treatment of eye disease
IL275636A (en)	2020-08-31	Medical combination for cancer treatment
HUP1100290A2 (en)	2012-12-28	Combination compositions for the treatment of proliferative diseases
IL234796B (en)	2018-02-28	Compounds for the treatment of diseases related to ischemia-reperfusion
PL2593423T3 (pl)	2015-03-31	Proces wytwarzania środków kontrastowych
ZA201400488B (en)	2014-11-26	Compounds for the treatment of cancers associated with human papillomavirus
PL2456445T3 (pl)	2014-10-31	Środek do leczenia chorób skóry
IL236870B (en)	2019-11-28	History of hydroxystatin for the treatment of osteoarthritis
EP2531186A4 (en)	2013-07-17	TREATMENT OF HAIR DRESSES
IL232294A0 (en)	2014-06-30	Preparations for the treatment of diabetes
GB201207476D0 (en)	2012-06-13	pharmaceutical for the treatment of leishmaniasis
ZA201304121B (en)	2014-08-27	Arlysulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders
HK1188955A (en)	2014-05-23	Methods for treating diseases of the retina
GB201019158D0 (en)	2010-12-29	Novel compounds and improved treatments for glaucoma
GB201009094D0 (en)	2010-07-14	Compounds for the treatment of closridium difficile-associated disease